Jeeva at Clinical Research Events

Behind every breakthrough in healthcare is a shared commitment to improving lives.🌍

BIO International Convention 2026 brings together innovators, researchers, and industry leaders from across the global life sciences ecosystem, and Jeeva Clinical Trials is excited to be exhibiting at the event.

Harsha Rajasimha, our Founder & CEO, Param Singh, our Chief Operating Officer, and Arianna Hiciano, our Executive Assistant, will be showcasing how AI-powered pre-trial intelligence can help modernize clinical development workflows and support the future of clinical research.

📅 June 22–25, 2026
📍 San Diego, CA, USA
📌 Visit us at BIO Exhibit #1711

If you’ll be joining BIO 2026, let’s connect and explore how AI-powered and connected clinical infrastructure can help shape the future of clinical research.

🔗 Register: Here

🌐 Learn more about Jeeva Clinical Trials: Here

Jeeva Clinical Trials is excited to be part of BIO Week 2026, hosted by BLPN, a leading gathering that brings together innovators, investors, founders, and strategic partners from across the global life sciences ecosystem.

Join Harsha Rajasimha, our Founder & CEO, Founding Member of BLPN Club and Recipient of the BLPN Money Ball Investment in 2025, along with Param Singh, our Chief Operating Officer, and Arianna Hiciano, our Executive Assistant at BLPN BIO Week 2026 as we engage in conversations around AI-powered pre-trial intelligence, innovation, collaboration, and the future of clinical research.

We’re looking forward to connecting with biopharma innovators, sponsors, investors, and strategic partners to explore new opportunities for collaboration and help advance modern clinical development.

Mark Your Calendar
📅 June 21–24, 2026
📍 San Diego, CA, USA

🤝 Interested in exploring partnerships, AI-powered pre-trial intelligence, or innovative approaches to clinical development? Schedule a meeting with Harsha: Here

See you at BLPN BIO Week 2026.

🔗 Register: Here

🌍 Exciting news! We are heading to United Mitochondrial Disease Foundation ‘s Mitochondrial Medicine Conference (MITO MED 2026), one of the world’s leading gatherings dedicated to advancing mitochondrial medicine, research, and patient care.

💡 Harsha Rajasimha,our Founder & CEO, will be attending the conference and engaging with researchers, clinicians, patient advocates, and industry leaders from around the world.

📅 June 17–20, 2026
📍 Orlando, FL, USA

We look forward to participating in conversations around mitochondrial medicine and exploring how AI-powered pre-trial intelligence and modern clinical development workflows can support innovation in rare disease research.

🔗 Register: Here

The future of clinical research will be shaped by stronger collaboration, smarter technology, and more connected healthcare ecosystems. 🚀

Jeeva Clinical Trials is excited to be exhibiting at DIA 2026, where industry leaders will come together to exchange ideas, share insights, and explore the future of healthcare innovation.

📅 June 14–18, 2026
📍 Philadelphia, PA, USA

Join Harsha Rajasimha, our Founder & CEO, Param Singh, our Chief Operating Officer, and Arianna Hiciano, our Executive Assistant at DIA 2026 to explore how AI-powered pre-trial intelligence and connected clinical infrastructure can help streamline clinical development workflows and support the future of clinical research.

We look forward to connecting with sponsors, CROs, research organizations, and industry leaders to discuss the evolving landscape of clinical development and digital innovation.

🔗 Register: Here

The future of Rare Disease innovation will be shaped through stronger collaboration, smarter technology, and more connected healthcare ecosystems. 🌍

Jeeva Clinical Trials is excited to share that Harsha Rajasimha, our Founder & CEO, will be attending World Orphan Drug Congress USA 2026, one of the leading global events bringing together leaders across biotech, healthcare, research, and patient advocacy.

📅 June 9–11, 2026
📍 Boston, MA, USA

The event offers an opportunity to engage in important conversations around rare disease innovation, clinical research, patient engagement, and the future of therapeutic development.

We look forward to engaging with industry leaders and contributing perspectives on modernizing clinical research infrastructure.

🔗 Register: Here

🌐 Learn more about Jeeva Clinical Trials: Here

Harsha Rajasimha, our Founder & CEO, will be speaking at HITLAB‘s virtual May Symposium: Review of New York City Health Innovation Week 2026.

This virtual session will bring together conversations around the future of healthcare innovation, digital transformation, and the evolving role of technology in improving patient outcomes and care delivery.

At Jeeva Clinical Trials, we believe meaningful innovation happens when technology, accessibility, and patient-centered thinking come together to shape better healthcare experiences for everyone.

Session Details:
📅 May 28, 2026
⏰ 11:00 AM – 2:00 PM ET

Join the free virtual session and be part of the conversation shaping the future of digital health and healthcare innovation.

🔗 Register: Here